Cargando…
Effects of Thiazolidinedione and New Antidiabetic Agents on Stroke
Patients with hyperglycemia are at a high risk of cardio- and cerebrovascular diseases. Diabetes patients also have poor outcomes after cerebrovascular disease development. Several classes of drugs are used for diabetes management in clinical practice. Thiazolidinedione (TZD) was introduced in the l...
Autores principales: | Ahn, Chang Ho, Lim, Soo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Stroke Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6549069/ https://www.ncbi.nlm.nih.gov/pubmed/31161759 http://dx.doi.org/10.5853/jos.2019.00038 |
Ejemplares similares
-
Discovery Potent of Thiazolidinedione Derivatives as Antioxidant, α-Amylase Inhibitor, and Antidiabetic Agent
por: Sameeh, Manal Y., et al.
Publicado: (2021) -
New Succinimide–Thiazolidinedione Hybrids as Multitarget Antidiabetic Agents: Design, Synthesis, Bioevaluation, and Molecular Modelling Studies
por: Huneif, Mohammed A., et al.
Publicado: (2023) -
Bone Loss in Diabetes: Use of Antidiabetic Thiazolidinediones and Secondary Osteoporosis
por: Lecka-Czernik, Beata
Publicado: (2010) -
Targeting Peroxisome Proliferator-Activated Receptors Using Thiazolidinediones: Strategy for Design of Novel Antidiabetic Drugs
por: Thangavel, Neelaveni, et al.
Publicado: (2017) -
Discovery of Novel Thiazolidinedione-Derivatives with Multi-Modal Antidiabetic Activities In Vitro and In Silico
por: Arineitwe, Charles, et al.
Publicado: (2023)